The DOI matches its Crossref record.
Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
Abstract
Guillain-Barré syndrome has been considered to be primarily an acute inflammatory demyelinating polyneuropathy (AIDP). Our experience with Guillain-Barré syndrome in northern China differs from the traditional concept. Electrophysiologically and pathologically, most of our patients have motor axonal degeneration with minimal cellular inflammation, which we have termed 'acute motor axonal neuropathy' (AMAN). The current studies were undertaken to characterize prospectively the clinical, electrophysiological, and serological features of Guillain-Barré syndrome, defined clinically, in northern China. In 1991 and 1992, we characterized by electrodiagnostic criteria 129 Chinese patients with Guillain-Barré syndrome. The AMAN form was present in 65% of patients, the AIDP form in 24% and 11% were unclassifiable. For the 38 patients who presented from January to October, 1992, we performed serological assays for antibodies to Campylobacter jejuni and to glycolipids. Of these 38 patients, 55% had AMAN, 32% had AIDP and 13% were unclassifiable. Sixty-six percent of the 38 had serological evidence of recent C. jejuni infection as compared with 16% of village controls (P = 0.001). Seventy-six percent of AMAN patients and 42% of AIDP patients were seropositive. IgG anti-GM1 antibodies were more frequent in Guillain-Barré syndrome patients compared with village controls (42% versus 6%; P < 0.01). However, no statistically significant correlations were found between the pattern of disease, AMAN or AIDP, anti-glycolipid antibodies, or C. jejuni antibodies. Based on electrophysiological criteria, Guillain-Barré syndrome in northern China can be divided into two predominant forms: AIDP and AMAN. The AMAN form is more common and predominates in the yearly summer outbreaks of Guillain-Barré syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Hughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
Self-citationWillison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Yuki, N., & Hartung, H.-P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,260
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
Self-citationDiagnosis and management of Guillain–Barré syndrome in ten steps
Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., Bateman, K., Ferreira, M. L. B., Cornblath, D. R., van Doorn, P. A., Dourado, M. E., Hughes, R. A. C., Islam, B., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0250-9 · Cited by 910
Self-citationClinical features, pathogenesis, and treatment of Guillain-Barré syndrome
van Doorn, P. A., Ruts, L., & Jacobs, B. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70215-1 · Cited by 828
Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00517-1 · Cited by 697
Epidemiology of peripheral neuropathy.
Martyn, C. N., & Hughes, R. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.310 · Cited by 597
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Self-citationGuillain–Barré Syndrome Associated with Zika Virus Infection in Colombia
Parra, B., Lizarazo, J., Jiménez-Arango, J. A., Zea-Vera, A. F., González-Manrique, G., Vargas, J., Angarita, J. A., Zuñiga, G., Lopez-Gonzalez, R., Beltran, C. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605564 · Cited by 574
Self-citationHuman Campylobacteriosis in Developing Countries1
Coker, A. O., Isokpehi, R. D., Thomas, B. N., Amisu, K. O., & Obi, C. L. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0803.010233 · Cited by 530
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Self-citationThe microbiological safety of minimally processed vegetables
Francis, G. A., Thomas, C., & O'beirne, D. (1999) · International Journal of Food Science and Technology · doi:10.1046/j.1365-2621.1999.00253.x · Cited by 485
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Odaka, M., Yuki, N., Yamada, M., Koga, M., Takemi, T., Hirata, K., & Kuwabara, S. (2003) · Brain · doi:10.1093/brain/awg233 · Cited by 440
Pathogenesis of Guillain–Barré syndrome
Hughes, R. A. C., Hadden, R. D. M., Gregson, N. A., & Smith, K. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00195-2 · Cited by 405
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
Griffin, J. W., Li, C. Y., Ho, T. W., Tian, M., Gao, C. Y., Xue, P., Mishu, B., Cornblath, D. R., Macko, C., McKhann, G. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390105 · Cited by 403
Self-citationHahn, A. F. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12308-x · Cited by 395
Preceding infections, immune factors, and outcome in Guillain–Barré syndrome
Hadden, R. D. M., Karch, H., Hartung, H.-P., Zielasek, J., Weissbrich, B., Schubert, J., Weishaupt, A., Cornblath, D. R., Swan, A. V., Hughes, R. A. C., et al. (2001) · Neurology · doi:10.1212/wnl.56.6.758 · Cited by 375
Self-citationOgawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., & Yuki, N. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f · Cited by 333
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 329
Self-citationKuwabara, S., Yuki, N., Koga, M., Hattori, T., Matsuura, D., Miyake, M., & Noda, M. (1998) · Annals of Neurology · doi:10.1002/ana.410440210 · Cited by 311
Poliomyelitis-like illness due to Japanese encephalitis virus
Solomon, T., Kneen, R., Dung, N. M., Khanh, V. C., Thuy, T. T. N., Ha, D. Q., Day, N. P., Nisalak, A., Vaughn, D. W., & White, N. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07509-0 · Cited by 287
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
Griffin, J. W., Li, C. Y., Macko, C., Ho, T. W., Hsieh, S. T., Xue, P., Wang, F. A., Cornblath, D. R., McKhann, G. M., & Asbury, A. K. (1996) · Journal of Neurocytology · doi:10.1007/bf02284784 · Cited by 262
Self-citationAssociation between Campylobacter Infection and Guillain‐Barré Syndrome
Allos, B. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513783 · Cited by 261
Kaida, K., Ariga, T., & Yu, R. K. (2009) · Glycobiology · doi:10.1093/glycob/cwp027 · Cited by 155
Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist’s journey
YUKI, N. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.299 · Cited by 109
Prendergast, M. M., Lastovica, A. J., & Moran, A. P. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3649-3655.1998 · Cited by 89
“Characteristically, 76% of the AMAN and 42% of the AIDP GBS patients have serologic evidence consistent with recent C. jejuni infection ( 17 , 30).”
Background
Metadata
- Authors
- Ho, T. W., Mishu, B., Li, C. Y., Gao, C. Y., Cornblath, D. R., Griffin, J. W., Asbury, A. K., Blaser, M. J., & McKhann, G. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1995
- Volume
- 118
- Issue
- 3
- Pages
- 597-605
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2147467901
- Cited by
- 764
- References
- 0
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.